Literature DB >> 14966095

Change in neurocognitive functioning after treatment with cranial radiation in childhood.

Brenda J Spiegler1, Eric Bouffet, Mark L Greenberg, James T Rutka, Donald J Mabbott.   

Abstract

PURPOSE: To evaluate the pattern of stability and change over time across multiple domains of neurocognitive function in radiated survivors of posterior fossa (PF) tumors. PATIENTS AND METHODS: Thirty-four children (25 males) treated for malignant PF tumors were observed with serial clinical neuropsychologic assessments. Thirty patients were treated for medulloblastoma and four patients were treated for ependymoma. Twelve patients were treated with reduced-dose and 21 patients were treated with standard-dose cranial radiation. All patients received an additional boost to the PF. One patient was treated with PF radiation only. Standardized neuropsychologic tests were administered at different times after diagnosis for each child. The rate of change in scores was determined using a mixed model regression.
RESULTS: Results showed a 2- to 4-point decline per year in intelligence scores. For our relatively young sample, intellectual function declined quickly in the first few years after treatment, and then more gradually. Significant declines in visual-motor integration, visual memory, verbal fluency, and executive functioning were also documented. No decline was evident for verbal memory and receptive vocabulary.
CONCLUSION: Cranial radiation is associated with a decline in multiple neurocognitive domains, with a few notable exceptions. Our results must be interpreted in the context of common limitations of clinical research, including patient variability, changes in test versions, small sample size, and clinical referral bias.

Entities:  

Mesh:

Year:  2004        PMID: 14966095     DOI: 10.1200/JCO.2004.05.186

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  128 in total

1.  White matter compromise predicts poor intellectual outcome in survivors of pediatric low-grade glioma.

Authors:  Fang Liu; Nadia Scantlebury; Uri Tabori; Eric Bouffet; Suzanne Laughlin; Douglas Strother; Dina McConnell; Juliette Hukin; Chris Fryer; Marie-Eve Brière; Isabelle Montour-Proulx; Daniel Keene; Frank Wang; Donald J Mabbott
Journal:  Neuro Oncol       Date:  2014-11-13       Impact factor: 12.300

Review 2.  Genetic and molecular alterations across medulloblastoma subgroups.

Authors:  Patryk Skowron; Vijay Ramaswamy; Michael D Taylor
Journal:  J Mol Med (Berl)       Date:  2015-09-09       Impact factor: 4.599

3.  Visualization and segmentation of reciprocal cerebrocerebellar pathways in the healthy and injured brain.

Authors:  Nicole Law; Mark Greenberg; Eric Bouffet; Suzanne Laughlin; Michael D Taylor; David Malkin; Fang Liu; Iska Moxon-Emre; Nadia Scantlebury; Jovanka Skocic; Donald Mabbott
Journal:  Hum Brain Mapp       Date:  2015-04-14       Impact factor: 5.038

4.  Multimodal treatments combined with gamma knife surgery for primary atypical teratoid/rhabdoid tumor of the central nervous system: a single-institute experience of 18 patients.

Authors:  Yan-Ming Ren; Xia Wu; Chao You; Yue-Kang Zhang; Qiang Li; Yan Ju
Journal:  Childs Nerv Syst       Date:  2017-12-07       Impact factor: 1.475

5.  Executive functioning, academic skills, and quality of life in pediatric patients with brain tumors post-proton radiation therapy.

Authors:  Lea M Ventura; Julie A Grieco; Casey L Evans; Karen A Kuhlthau; Shannon M MacDonald; Nancy J Tarbell; Torunn I Yock; Margaret B Pulsifer
Journal:  J Neurooncol       Date:  2017-12-06       Impact factor: 4.130

6.  Parenting stress and neurocognitive late effects in childhood cancer survivors.

Authors:  Sunita K Patel; Andrew L Wong; Michelle Cuevas; Hillary Van Horn
Journal:  Psychooncology       Date:  2012-10-25       Impact factor: 3.894

7.  Cerebral white matter integrity and executive function in adult survivors of childhood medulloblastoma.

Authors:  Tara M Brinkman; Wilburn E Reddick; Joshua Luxton; John O Glass; Noah D Sabin; Deo Kumar Srivastava; Leslie L Robison; Melissa M Hudson; Kevin R Krull
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

Review 8.  Preventing neurocognitive late effects in childhood cancer survivors.

Authors:  Martha A Askins; Bartlett D Moore
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

9.  Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma.

Authors:  Nadia Barahmani; Sarah Carpentieri; Xio-Nan Li; Tao Wang; Yumei Cao; Laura Howe; Lindsay Kilburn; Murali Chintagumpala; Ching Lau; M Fatih Okcu
Journal:  Neuro Oncol       Date:  2008-10-24       Impact factor: 12.300

10.  The Childhood Cancer Survivor Study-Neurocognitive Questionnaire (CCSS-NCQ) revised: item response analysis and concurrent validity.

Authors:  Kelly M Kenzik; I-Chan Huang; Tara M Brinkman; Brandon Baughman; Kirsten K Ness; Elizabeth A Shenkman; Melissa M Hudson; Leslie L Robison; Kevin R Krull
Journal:  Neuropsychology       Date:  2014-06-16       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.